Factors associated with fluoxetine and norfluoxetine plasma concentrations and clinical response in Mexican patients with mental disorders-Reference-Cited by-同舟云学术

Factors associated with fluoxetine and norfluoxetine plasma concentrations and clinical response in Mexican patients with mental disorders

Published:2021-09-14 Issue:5 Volume:9 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Sagahón‐Azúa Julia¹^ORCID,Medellín‐Garibay Susanna Edith¹,Chávez‐Castillo Cinthya Eloisa¹,González‐Salinas César Guillermo²,Milán‐Segovia Rosa del Carmen¹^ORCID,Romano‐Moreno Silvia¹

Affiliation:

1. Department of Pharmacy Faculty of Chemical Sciences Autonomous University of San Luis Potosí San Luis Potosí México

2. Psychiatric Service Central Hospital “Dr. Ignacio Morones Prieto” San Luis Potosí México

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.864

Reference40 articles.

1. Simultaneous determination of fluoxetine and norfluoxetine in dried blood spots using high-performance liquid chromatography-tandem mass spectrometry

2. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

3. Classics in Chemical Neuroscience: Fluoxetine (Prozac)

4. CoEL.Medication Guide Reference ID: 4074888.2009. Food and Drug Administration. Accessed December 10 2020.https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103 021235s023lbl.pdf

5. Fluoxetine: a case history of its discovery and preclinical development

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UPLC-MS/MS determination of 71 neuropsychotropic drugs in human serum;Heliyon;2024-06

2. Impact of Cytochrome P450 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects Among Children and Adolescents Treated with Fluoxetine;Journal of Child and Adolescent Psychopharmacology;2024-02-01

3. Regulation of Hippocampal GABAergic Transmission by Fluoxetine and Its Metabolite Norfluoxetine;Receptors;2024-01-04

4. Pharmacogenomic and pharmacometabolomic biomarkers of the efficacy and safety of antidepressants: focus on selective serotonin reuptake inhibitors;S.S. Korsakov Journal of Neurology and Psychiatry;2024

5. Pharmacogenetic Variants Associated with Fluoxetine Pharmacokinetics from a Bioequivalence Study in Healthy Subjects;Journal of Personalized Medicine;2023-09-01